AI Science Tracker
EN

Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells.

Affiliation not stated in the reviewed material · 30 Oct 2025 · medicine

Discovery

Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Full Methods/Results describe deconvolution plus supervised models over three breast-cancer cohorts (255 patients) to predict chemotherapy response and identify cell-type/interactions associated with response; performance assessed across cohorts against bulk-expression baseline. Bounded retrospective predictive finding; no causal treatment benefit claimed.

Technology: Full Methods/Results describe deconvolution plus supervised models over three breast-cancer cohorts (255 patients) to predict chemotherapy response and identify cell-type/interactions associated with response; performance assessed across cohorts against bulk-expression baseline. Bounded retrospective predictive finding; no causal treatment benefit claimed.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Full Methods/Results describe deconvolution plus supervised models over three breast-cancer cohorts (255 patients) to predict chemotherapy response and identify cell-type/interactions associated with response; performance assessed across cohorts against bulk-expression baseline. Bounded retrospective predictive finding; no causal treatment benefit claimed.
Limitation / still unknown
The three cohorts comprise 255 retrospective patients; prediction and cell-interaction associations do not establish causal treatment effects or prospective clinical benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12807300/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.